approval
savePANTOPRAZOLE SODIUM — FDA approval
community read0 votes
Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalPANTOPRAZOLE SODIUM — FDA approvalOct 15, 2025 · 361d ago
- approvalPANTOPRAZOLE SODIUM — FDA approvalOct 15, 2025 · 361d ago
- approvalPANTOPRAZOLE SODIUM — FDA approvalOct 1, 2025 · 375d ago
- approvalPANTOPRAZOLE SODIUM — FDA approvalOct 1, 2025 · 375d ago
- approvalPANTOPRAZOLE SODIUM — FDA approvalOct 1, 2025 · 375d ago
- approvalPANTOPRAZOLE SODIUM — FDA approvalOct 5, 2023 · 1102d ago
- approvalPANTOPRAZOLE SODIUM — FDA approvalMay 18, 2022 · 1607d ago
- approvalPANTOPRAZOLE SODIUM — FDA approvalMar 5, 2021 · 2046d ago
same company · ±60 days · 6
- approvalHYRIMOZ: HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJul 18, 2022
- approvalHYRIMOZ: HYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJul 18, 2022
- approvalGLATIRAMER ACETATE: GLATOPA (GLATIRAMER ACETATE) — FDA approvalSep 21, 2022
- approvalGLATIRAMER ACETATE: GLATOPA (GLATIRAMER ACETATE) — FDA approvalSep 21, 2022
- approvalGLATIRAMER ACETATE: GLATOPA (GLATIRAMER ACETATE) — FDA approvalSep 21, 2022
- approvalGLATIRAMER ACETATE: GLATOPA (GLATIRAMER ACETATE) — FDA approvalSep 21, 2022
comments(0)
5-min edit window · permanent after that